Harpoon Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Harpoon Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2022.
  • Harpoon Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$12.1M, a 2.1% decline year-over-year.
  • Harpoon Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$39.1M, a 45% increase year-over-year.
  • Harpoon Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$68.3M, a 41.5% increase from 2021.
  • Harpoon Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$117M, a 127% decline from 2020.
  • Harpoon Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$51.3M, a 11.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$68.3M +$48.4M +41.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 -$117M -$65.4M -127% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 -$51.3M +$6.88M +11.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-27
2019 -$58.2M -$30.5M -110% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 -$27.7M -$11.2M -67.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 -$16.5M -$5.38M -48.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$11.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.